TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
1.370
-0.200 (-12.74%)
At close: Mar 10, 2025, 4:00 PM
1.356
-0.014 (-0.99%)
After-hours: Mar 10, 2025, 7:59 PM EST
TransCode Therapeutics Employees
TransCode Therapeutics had 10 employees as of December 31, 2023. The number of employees decreased by 9 or -47.37% compared to the previous year.
Employees
10
Change (1Y)
-9
Growth (1Y)
-47.37%
Revenue / Employee
n/a
Profits / Employee
-$1,492,656
Market Cap
953.86K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 10 | -9 | -47.37% |
| Dec 31, 2022 | 19 | 10 | 111.11% |
| Dec 31, 2021 | 9 | 3 | 50.00% |
| Dec 31, 2020 | 6 | 0 | - |
| Dec 31, 2019 | 6 | - | - |
RNAZ News
- 13 days ago - TransCode Therapeutics, Inc. Announces Results of Special Meeting - PRNewsWire
- 4 weeks ago - TransCode Therapeutics Announces Completion of Cohort 3 Initial Dosing with Lead Candidate in Phase 1 Clinical Trial - PRNewsWire
- 4 weeks ago - TransCode Therapeutics, Inc. Announces Adjournment of Special Meeting and Information for Adjourned Special Meeting - PRNewsWire
- 7 weeks ago - TransCode Therapeutics Announces First Patient Dosed in Third Cohort with Lead Candidate in Phase 1 Clinical Trial - PRNewsWire
- 2 months ago - Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements - PRNewsWire
- 2 months ago - TransCode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary Results from First Cohort in Phase 1 TTX-MC138 Clinical Trial - PRNewsWire
- 3 months ago - TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split - GlobeNewsWire
- 3 months ago - TransCode Therapeutics, Inc. Announces $8 Million Private Placement - GlobeNewsWire